The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

Palghar: The Union health ministry has stopped operations and production of Aveo Pharmaceuticals Ltd. (Aveo) following ...

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

Maharashtra's Food and Drug Administration has issued a show cause notice to a pharmaceutical company here for alleged ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Lebanon County is expected to receive $3.6 million from a second wave of opioid settlement funds, which officials will use create new programs.

The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...